Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
Xiaoyu Liang, Fen‐Fang Hong, Shu‐Long Yang
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 1871-1883
Open Access | Times Cited: 16

Showing 16 citing articles:

Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36‐mediated ferroptosis
Xin Li, Ziwei Li, Xin Dong, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 3042-3056
Closed Access | Times Cited: 33
Astragaloside IV, as a potential anticancer agent
Dongqin Xia, Wenjie Li, Ce Tang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 30
Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review
Mei-Lian Chen, Binlan Fu, Hao Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications
Dongjie Wu, Jing Liu, Ziwei Guo, et al.
International Immunopharmacology (2025) Vol. 157, pp. 114708-114708
Open Access
Cuscutae Semen in depression-induced ovarian dysfunction: metabolomics with UPLC-QToF-MS in female mice
Ying Xie, Zhaoxiang Zeng, Jinrong Zhang, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Network pharmacology and experimental validation to reveal the pharmacological mechanisms of Astragaloside Ⅳ in treating intervertebral disc degeneration
Deta Chen, Tian-You Fan, Kanghui Sun, et al.
European Journal of Pharmacology (2024) Vol. 982, pp. 176951-176951
Open Access | Times Cited: 3
Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ1–42 through Nrf2/HO-1 and NF-κB signaling pathway in mice
Shiyu Jin, Xin Wang, XiaoTong Xiang, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108335-108335
Closed Access | Times Cited: 19
α-Lipoic acid – a promising agent for attenuating inflammation and preventing steatohepatitis in rats fed a high-fat diet
Mateusz Zwierz, Adrian Chabowski, Klaudia Sztolsztener
Archives of Biochemistry and Biophysics (2023) Vol. 750, pp. 109811-109811
Open Access | Times Cited: 7
Lipoxygenases in chronic liver diseases: current insights and future perspectives
Lena Heinrich, Richell Booijink, Amit Khurana, et al.
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 3, pp. 188-205
Open Access | Times Cited: 9
PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway
Zeyu Li, Kanglin Wu, Yi Zou, et al.
Toxicology and Applied Pharmacology (2022) Vol. 448, pp. 116074-116074
Closed Access | Times Cited: 5
Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway
Yan Meng, Shengxue Yu, Fang Zhao, et al.
Neural Plasticity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 5
Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model
Seyedeh Parisa Hosseini, Shirin Farivar, Ramazan Rezaei, et al.
DARU Journal of Pharmaceutical Sciences (2023) Vol. 31, Iss. 1, pp. 29-37
Closed Access | Times Cited: 2
Could Cyclosiversioside F Serve as a Dietary Supplement to Prevent Obesity and Relevant Disorders?
Siqi Qin, Junren Chen, Kexin Zhong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13762-13762
Open Access | Times Cited: 2
Functional compounds rapid screening strategy for health food function-formula-component integrated quality control by syndrome correlation-network analysis
Ruolan Song, Jiamu Ma, Xiangjian Zhong, et al.
Journal of Future Foods (2024) Vol. 5, Iss. 1, pp. 94-106
Open Access
Astragaloside IV prevents enterovirus 71-induced pyroptosis through the TCF12-TXNIP-Keap1/Nrf2 axis
Jinfang Hao, Xiaoyan Zhang, Hui Wang, et al.
Journal of Functional Foods (2024) Vol. 118, pp. 106290-106290
Open Access
Astragaloside IV and Cycloastragenol Promote Liver Regeneration through Regulation of Hepatic Oxidative Homeostasis and Glucose/Lipid Metabolism
Yanghao Li, Xu Yang, Xiang Li, et al.
Phytomedicine (2024) Vol. 135, pp. 156165-156165
Closed Access
Effect of astragaloside on expression of smac, cytochrome C and caspase-3 in hepatic tissue of acute hepatic failure induced by D-Gal NLPS
Lingli Qin, Jinxi Lu, Sun Ji
Materials Express (2023) Vol. 13, Iss. 5, pp. 862-867
Closed Access
Astragaloside IV relieves IL-1β-induced human nucleus pulposus cells degeneration through modulating PI3K/Akt signaling pathway
Lu Zhang, Junsheng Gao, Zhentao Li, et al.
Medicine (2023) Vol. 102, Iss. 33, pp. e34815-e34815
Open Access
Page 1

Scroll to top